Women's Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Karolinska Institute, Stockholm
Active management of third stage of labor greatly reduces postpartum hemorrhage
April 17th, 2005
A study conducted in Luanda, Angola, by Karolinska Institute public health researchers demonstrated that active management of the third stage of labor significantly reduces occurrence of postpartum hemorrhage (PPH), the primary cause of maternal mortality worldwide. This purpose of the study "was to introduce Uniject (a new disposable device for administration of 10 IU oxytocin) as part of active management of the third stage of labor (AMTL) and try to reduce PPH," wrote R.T. Strand and colleagues. "Postpartum hemorrhage is the single most common cause of maternal death in the world, and oxytocin is known to be effective for its prevention and...
Source: Women's Health Law Weekly (2005-04-17)
|
